Motiva Flora Tissue Expander Debuts in the U.S.
Establishment Labs Holdings Inc. announces the first-ever utilization of the Motiva Flora SmoothSilk Tissue Expander in the United States, following its recent FDA clearance.
Establishment Labs Holdings Inc. announces the first-ever utilization of the Motiva Flora SmoothSilk Tissue Expander in the United States, following its recent FDA clearance.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.